Clinical trial management and monitoring
Brillance manages and monitors Phase I–IV clinical trials, covering local and large international projects across many therapeutic areas.
Source: LinkedIn company description · Retrieved November 17, 2026

Brillance is a privately held Polish contract research organization providing clinical-trial management and monitoring services for the pharmaceutical industry.
The company focuses on research and development services for the medical, pharmaceutical, and biotechnology industries. Its stated coverage includes Poland, the Czech Republic, and the Slovak Republic; it began activities in 2004.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its clients include Polish and international medical, pharmaceutical, and biotechnology companies.
Brillance manages and monitors Phase I–IV clinical trials, covering local and large international projects across many therapeutic areas.
Source: LinkedIn company description · Retrieved November 17, 2026
The company offers data management services as an additional service to clients.
Source: LinkedIn company description · Retrieved November 17, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on November 17, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 18, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 17, 2026, November 5, 2026 and November 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.